Ipilimumab – Indications, Dosage, and Side Effects
1. Introduction & Mechanism of Action Ipilimumab is a humanized IgG4 monoclonal antibody that selectively binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), an inhibitory receptor expressed on activated T cells…
